Peripheral Arterial Disease Trial, Recruiting NCT06693245 Sponsor: Chengdu University of Traditional Chinese Medicine Condition: Peripheral Arterial Disease
Back to Peripheral Arterial Disease

Peripheral Arterial Disease Trial, Recruiting

NCT06693245
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 to 90 years old
  • People whose life expectancy is greater than 12 months
  • People with a diagnosis of primary varicose veins (a condition where leg veins become enlarged and twisted), with disease severity falling within a specific range (called CEAP classification C2–C6), affecting the main vein running along the inside of the leg (called the great saphenous vein or GSV), along with symptoms such as pain, burning, heaviness, fatigue, itchy skin, or night cramps
  • People whose ultrasound scan shows the affected leg vein measures between 3mm and 12mm wide while standing
  • People whose ultrasound scan confirms the affected leg vein sits within the surrounding tissue layer or is more than 1cm below the skin surface
  • People having the microwave vein treatment on one leg only
  • People who are willing to attend all check-ups and examinations required by the study

Who may not be able to join:

  • People who have a blood clot in the great saphenous vein, or a clot in the deeper leg veins, or a previous history of deep vein clots or a blood clot in the lungs
  • People whose varicose veins have come back after a previous varicose vein operation
  • People whose great saphenous vein is so severely twisted that the treatment tube (catheter) is unlikely to be able to pass through it
  • People with severely reduced blood flow to the lower legs, as measured by a specific blood pressure comparison test (ankle brachial pressure index below 0.8)
  • People with a known allergy to any of the medicines or materials used in this study
  • People who have a pacemaker or defibrillator already fitted, or who are currently taking regular blood-thinning medication (such as warfarin or heparin)
  • People who are pregnant or breastfeeding
  • People who are unable or unwilling to take part in the study
  • People who are currently taking part in another medical research study involving a drug or device
  • People currently being treated for a skin cancer (other than certain common, less serious types of skin cancer)
  • People who use narcotic or anti-inflammatory pain medicines every day to manage pain caused by their vein condition
  • People whom the treating doctor considers unsuitable for this type of vein treatment

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 86-18981885601

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Chengdu University of Traditional Chinese Medicine
Registry
ClinicalTrials.gov
Start date
1 December 2024
Est. completion
1 December 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Visual Analogue Scale (VAS) Pain Score; Basic data related to surgery

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov